Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1903 1
1915 1
1919 1
1923 1
1933 1
1945 4
1946 9
1947 6
1948 10
1949 30
1950 30
1951 54
1952 67
1953 74
1954 77
1955 66
1956 107
1957 61
1958 92
1959 85
1960 99
1961 152
1962 126
1963 90
1964 57
1965 142
1966 175
1967 223
1968 232
1969 290
1970 525
1971 576
1972 517
1973 440
1974 381
1975 375
1976 374
1977 330
1978 313
1979 287
1980 295
1981 336
1982 334
1983 409
1984 537
1985 533
1986 650
1987 799
1988 767
1989 890
1990 1012
1991 999
1992 1075
1993 1191
1994 1192
1995 1310
1996 1338
1997 1618
1998 1656
1999 1901
2000 1982
2001 1966
2002 2282
2003 2602
2004 2765
2005 2889
2006 3469
2007 3709
2008 3970
2009 4269
2010 4791
2011 5226
2012 5651
2013 6081
2014 6260
2015 6877
2016 7295
2017 7661
2018 7899
2019 8266
2020 9692
2021 10449
2022 10308
2023 10015
2024 3761

Text availability

Article attribute

Article type

Publication date

Search Results

148,551 results

Results by year

Filters applied: . Clear all
Page 1
Challenges in the diagnosis of Parkinson's disease.
Tolosa E, Garrido A, Scholz SW, Poewe W. Tolosa E, et al. Lancet Neurol. 2021 May;20(5):385-397. doi: 10.1016/S1474-4422(21)00030-2. Lancet Neurol. 2021. PMID: 33894193 Free PMC article. Review.
Parkinson's disease is the second most common neurodegenerative disease and its prevalence has been projected to double over the next 30 years. An accurate diagnosis of Parkinson's disease remains challenging and the characterisati …
Parkinson's disease is the second most common neurodegenerative disease and its prevalence has been projected to …
Parkinson's disease.
Kalia LV, Lang AE. Kalia LV, et al. Lancet. 2015 Aug 29;386(9996):896-912. doi: 10.1016/S0140-6736(14)61393-3. Epub 2015 Apr 19. Lancet. 2015. PMID: 25904081 Review.
Parkinson's disease is a neurological disorder with evolving layers of complexity. ...In this Seminar, we review these complexities and challenges of Parkinson's disease....
Parkinson's disease is a neurological disorder with evolving layers of complexity. ...In this Seminar, we review these …
Parkinson's Disease and Parkinsonism.
Hayes MT. Hayes MT. Am J Med. 2019 Jul;132(7):802-807. doi: 10.1016/j.amjmed.2019.03.001. Epub 2019 Mar 16. Am J Med. 2019. PMID: 30890425 Review.
Parkinson's disease is a progressive neurodegenerative disease characterized by tremor and bradykinesia and is a common neurologic ailment. ...There are a number of other extrapyramidal conditions that can make the diagnosis challenging. Unlike other n …
Parkinson's disease is a progressive neurodegenerative disease characterized by tremor and bradykinesia and is a …
Parkinson's disease: a review.
Beitz JM. Beitz JM. Front Biosci (Schol Ed). 2014 Jan 1;6(1):65-74. doi: 10.2741/s415. Front Biosci (Schol Ed). 2014. PMID: 24389262 Free article. Review.
Parkinson's Disease is the second most common progressive neurodegenerative disorder affecting older American adults and is predicted to increase in prevalence as the United States population ages. Resulting from a pathophysiologic loss or degeneration of dop …
Parkinson's Disease is the second most common progressive neurodegenerative disorder affecting older American adults an …
Parkinson's disease treatment: past, present, and future.
Elsworth JD. Elsworth JD. J Neural Transm (Vienna). 2020 May;127(5):785-791. doi: 10.1007/s00702-020-02167-1. Epub 2020 Mar 14. J Neural Transm (Vienna). 2020. PMID: 32172471 Free PMC article. Review.
The substantial contributions of Dr. Gerald Stern to past and current treatments for Parkinson's disease patients are reviewed, which form the foundation for an evaluation of future options to control symptoms and halt progression of the disease. ...Su …
The substantial contributions of Dr. Gerald Stern to past and current treatments for Parkinson's disease patients are r …
Parkinson's Disease.
Reich SG, Savitt JM. Reich SG, et al. Med Clin North Am. 2019 Mar;103(2):337-350. doi: 10.1016/j.mcna.2018.10.014. Epub 2018 Dec 3. Med Clin North Am. 2019. PMID: 30704685 Review.
The diagnosis of Parkinson disease (PD) is based on the presence of bradykinesia and either resting tremor or rigidity and there should be no features from the history or examination to suggest an alternative cause of parkinsonism. ...
The diagnosis of Parkinson disease (PD) is based on the presence of bradykinesia and either resting tremor or rigidity and the …
Epidemiology of Parkinson's disease.
Tysnes OB, Storstein A. Tysnes OB, et al. J Neural Transm (Vienna). 2017 Aug;124(8):901-905. doi: 10.1007/s00702-017-1686-y. Epub 2017 Feb 1. J Neural Transm (Vienna). 2017. PMID: 28150045 Review.
Parkinson's disease (PD) affects 1-2 per 1000 of the population at any time. ...Increasing knowledge on genetic and environmental risk factors of PD will probably elucidate the cause of this disease within the near future....
Parkinson's disease (PD) affects 1-2 per 1000 of the population at any time. ...Increasing knowledge on genetic and env …
The epidemiology of Parkinson's disease: risk factors and prevention.
Ascherio A, Schwarzschild MA. Ascherio A, et al. Lancet Neurol. 2016 Nov;15(12):1257-1272. doi: 10.1016/S1474-4422(16)30230-7. Epub 2016 Oct 11. Lancet Neurol. 2016. PMID: 27751556 Review.
Since 2006, several longitudinal studies have assessed environmental or behavioural factors that seem to modify the risk of developing Parkinson's disease. Increased risk of Parkinson's disease has been associated with exposure to pestici …
Since 2006, several longitudinal studies have assessed environmental or behavioural factors that seem to modify the risk of developing Pa …
Parkinson's disease.
Samii A, Nutt JG, Ransom BR. Samii A, et al. Lancet. 2004 May 29;363(9423):1783-93. doi: 10.1016/S0140-6736(04)16305-8. Lancet. 2004. PMID: 15172778 Review.
Parkinson's disease is the most common serious movement disorder in the world, affecting about 1% of adults older than 60 years. ...Symptoms of Parkinson's disease respond in varying degrees to drugs, and surgery offers hope for patients …
Parkinson's disease is the most common serious movement disorder in the world, affecting about 1% of adults older than …
Parkinson's Disease in Women and Men: What's the Difference?
Cerri S, Mus L, Blandini F. Cerri S, et al. J Parkinsons Dis. 2019;9(3):501-515. doi: 10.3233/JPD-191683. J Parkinsons Dis. 2019. PMID: 31282427 Free PMC article. Review.
Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson's disease (PD). Risk of developing PD is twice as high in men than women, but women have a higher mortality rate and faster progres …
Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson's …
148,551 results
You have reached the last available page of results. Please see the User Guide for more information.